Galanin overexpressing transgenic mice

Neuropeptides

Volumn 36, Issue 2-3, 2002, Pages 145-156

  Crawley, Jacqueline N ^a   Mufson, Elliott J ^b   Hohmann, John G ^c   Teklemichael, Dawit ^c   Steiner, Robert A ^c   Holmberg, Kristina ^d   Xu, Zhi Qing D ^d   Blakeman, Karin Hygge ^e   Xu, Xiao Jun ^e   Wiesenfeld Hallin, Zsuzsanna ^e   Bartfai, Tamas ^d,f   Hökfelt, Tomas ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN;

ANALGESIA; ANIMAL BEHAVIOR; ANXIETY; CELL SURVIVAL; GENE OVEREXPRESSION; HIPPOCAMPUS; HORMONAL REGULATION; IN SITU HYBRIDIZATION; LEARNING; MEMORY; MOSSY FIBER; NEUROENDOCRINOLOGY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0036553033     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2002.0891     Document Type: Article

References (78)

1. SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells
2. Galanin and galanin antagonists: Molecular and biochemical perspectives
3. Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease
4. Galanin protects hippocampal neurons from the functional effects of anoxia
5. Galanin immunoreactivity within the primate basal forebrain: Evolutionary change between monkeys and apes
6. Anxiolytic-like action of centrally administered galanin
7. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease
8. Neuropathological stageing of Alzheimer-related changes
9. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease
10. Galanin receptor subtypes
11. Targeted overexpression of galanm in lactotrophs of transgenic mice induced hyperprolactinemia and pituitary hyperplasia
12. Effects of galanin and the galanin receptor antagonist galantide on plasma catecholamine levels during a psychosocial stress stimulus in rats
13. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia
14. Hyperinnervation of surviving neurons of the human basal nucleus of Meynert by galanin in dementias of Alzheimer's and Parkinson's disease
15. Neurobiology of galanin: Mechanisms and therapeutic potential for Alzheimer's disease
16. Biological actions of galanin
17. The role of galanin in feeding behavior
18. Long-term but not short-term plasticity at mossy fiber synapses is impaired in neural cell adhesion molecule-deficient mice
19. Human galanin reduces plasma norepinephrine levels in man
20. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein - Initial observations
21. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus
22. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: Kistochemical, autoradiographic, in vivo, and in vitro studies
23. Galanin-like immunoreactivity is increased in the postmorten cerebral cortex from patients with Alzheimer's disease
24. In situ hybridization detection of trkA mRNA in brain: Distribution, colocalization with p75 NGFR and up-regulation by nerve growth factor
25. Galanin: Basic research discoveries and therapeutic implications
26. Galanin and NPY, two peptides with multiple putative roles in the nervous system
27. Phenotypic changes in peripheral and central neurons induced by nerve injury: Focus on neuropeptides
28. Messenger plasticity in primary sensory neurons following axotomy and its functional implications
29. Creation and characterization of a mouse over-expressing galanin
30. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice
31. Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity
32. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus
33. Coexisting neurotransmitters in noradrenergic neurons
34. Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat
35. Role of galanin and galanin receptors in nociception and nerve injury: Studies using genetically modified mice
36. Mice overexpressing galanin have elevated heat noiceptive threshold
37. Galanin and galanin receptors
38. Phenotypic analysis of Galr1 knockout mice reveals a role for GALR1 galanin receptor in modulating seizure activity but not nerve regeneration
39. Galaninergic signaling and adenylate cyclase
40. Microdialysis in freely moving mice: Determination of acetylcholine, serotonin and noradrenaline release in galanin transgenic mice
41. Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic mice
42. Suppressed kindling epfieptogenesis in mice with ectopic overexpression of galanin
43. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease
44. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: Selective actions via GalR1 and GalR2 receptors
45. NTR-containing basal forebrain neurons in mice deficient in galanin
46. Modulation of hippocampal excitability and seizures by galanin
47. Galanin: An endogenous anticonvulsant?
48. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus
49. Galanin inhibits performance on rodent memory tasks
50. 1 against improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions
51. Anatomy and physiology of central galanin-containing pathways
52. Plasma galanin immunoreactivity in the rat after swimming
53. Anxiogenic-like action of galanin after intra-amygdala administration in the rat
54. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and the bed nucleus of the stria terminalis in aging, Alzheimer's disease, and Down's syndrome
55. Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: Distinct distribution from GALR1
56. Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat
57. Modulation of acetylcholine and serotonin transmission by galanin
58. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons
59. Neuropeptide messenger plasticity in the CNS neurons following axotomy
60. Distribution of galaninergic immunoreactivity in the brain of the mouse
61. Intraseptal galanin potentiates scopolamine impairment of delayed nonmatching to sample
62. Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus
63. Galanin inhibits long-term potentiation at Schaffer collateral-CA1 synapses in guinea-pig hippocampal slices
64. Effect of peripheral nerve injury on dorsal root ganglion neurons in the C57 BL/6J mouse: Marked changes both in cell numbers and neuropeptide expression
65. TrkA immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase and serotonin
66. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease
67. Acute and chronic restraint stress effects on [125I]-galanin binding in normotensive and hypertensive rat brain
68. Galanm - A novel biologically active peptide from porcine intestine
69. Galanin: A significant role in depression?
70. Galanin in sensory neurons in the spinal cord
71. Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin
72. Pharmacological evidence supporting a role for galanin in cognition and affect
73. Galanin regulates prolactin release and lactotroph proliferation
74. Spantide II, a novel tachykinin antagonist, and galanin inhibit plasma extravasation induced by antidromic C-fiber stimulation in rat hind paw
75. Galanin and spinal nociceptive mechanisms: Recent advances and therapeutic implications
76. Centrally administered galanin blocks morphine place preference in the mouse